• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内超声定义的正常与动脉粥样硬化冠状动脉节段中冠状动脉周围脂肪组织的CT衰减值

CT Attenuation of Pericoronary Adipose Tissue in Normal Versus Atherosclerotic Coronary Segments as Defined by Intravascular Ultrasound.

作者信息

Marwan Mohamed, Hell Michaela, Schuhbäck Annika, Gauss Sören, Bittner Daniel, Pflederer Tobias, Achenbach Stephan

机构信息

From the Department of Cardiology, University of Erlangen, Germany.

出版信息

J Comput Assist Tomogr. 2017 Sep/Oct;41(5):762-767. doi: 10.1097/RCT.0000000000000589.

DOI:10.1097/RCT.0000000000000589
PMID:28914752
Abstract

BACKGROUND

The factors influencing genesis of atherosclerosis at specific regions within the coronary arterial system are currently uncertain. Local mechanical factors such as shear stress as well as metabolic factors, including inflammatory mediators released from epicardial fat, have been proposed. We analyzed computed tomographic (CT) attenuation of pericoronary adipose tissue in normal versus atherosclerotic coronary segments as defined by intravascular ultrasound (IVUS).

PATIENTS AND METHODS

We evaluated the data sets of 29 patients who were referred for invasive coronary angiography and in whom IVUS of 1 coronary vessel was performed for clinical reasons. Coronary CT angiography was performed within 24 hours from invasive coronary angiography. Computed tomographic angiography was performed using dual-source CT (Siemens Healthcare; Forchheim, Germany). A contrast-enhanced volume data set was acquired (120 kV, 400 mA/rot, collimation 2 × 64 × 0.6 mm, 60-80 mL intravenous contrast agent). Intravascular ultrasound was performed using a 40-MHz IVUS catheter (Atlantis; Boston Scientific Corporation, Natick, Mass) and motorized pullback at 0.5 mm/s. Sixty corresponding coronary artery segments within the coronary artery system were identified in both dual source computed tomography and IVUS using bifurcation points as fiducial markers. In dual source computed tomography data sets, 8 serial parallel cross sections (2-mm slice thickness) were rendered orthogonal to the center line of the coronary artery for each segment. For each cross section, pericoronary adipose tissue within a radius of 3 mm from the coronary artery and enclosed within the epicardium (excluding coronary veins and myocardium) was manually traced and mean CT attenuation values were obtained. Intravascular ultrasound was used to define coronary segments as follows: presence of predominantly fibrous atherosclerotic plaque (hyperechoic), presence of predominantly lipid-rich atherosclerotic plaque (hypoechoic), and absence of atherosclerotic plaque.

RESULTS

In IVUS, 20 coronary segments with fibrous plaque, 20 segments with lipid-rich plaque, and 20 coronary segments without plaque were identified. The mean CT attenuation of pericoronary adipose tissue for segments with any coronary atherosclerotic plaque was -34 ± 14 Hounsfield units (HU), as compared with -56 ± 16 HU for segments without plaque (P = 0.005). The density of pericoronary fat in segments with fibrous versus lipid-rich plaque as defined by IVUS was not significantly different (-35 ± 19 HU vs -36 ± 16 HU, P = 0.8).

CONCLUSIONS

Mean CT attenuation of pericoronary adipose tissue is significantly lower for normal versus atherosclerotic coronary segments. This supports a hypothesis of different types of pericoronary adipose tissue, the more metabolically active of which might exert local effects on the coronary vessels, thus contributing to atherogenesis.

摘要

背景

目前尚不清楚影响冠状动脉系统特定区域动脉粥样硬化发生的因素。有人提出了局部机械因素,如剪切应力,以及代谢因素,包括心外膜脂肪释放的炎症介质。我们分析了血管内超声(IVUS)定义的正常与动脉粥样硬化冠状动脉节段周围冠状动脉脂肪组织的计算机断层扫描(CT)衰减情况。

患者和方法

我们评估了29例因侵入性冠状动脉造影而就诊的患者的数据集,出于临床原因对其中1支冠状动脉进行了IVUS检查。在侵入性冠状动脉造影后24小时内进行冠状动脉CT血管造影。使用双源CT(西门子医疗;德国福希海姆)进行计算机断层血管造影。获取增强对比剂的容积数据集(120 kV,400 mA/旋转,准直2×64×0.6 mm,60 - 80 mL静脉注射造影剂)。使用40 MHz的IVUS导管(Atlantis;波士顿科学公司,马萨诸塞州纳蒂克)进行血管内超声检查,并以0.5 mm/s的速度进行电动回撤。在双源计算机断层扫描和IVUS中,以分叉点作为基准标记,在冠状动脉系统中识别出60个相应的冠状动脉节段。在双源计算机断层扫描数据集中,为每个节段生成8个连续的平行横截面(切片厚度2 mm),使其与冠状动脉中心线正交。对于每个横截面,手动追踪距冠状动脉3 mm半径范围内且包绕在心外膜内(不包括冠状静脉和心肌)的冠状动脉周围脂肪组织,并获得平均CT衰减值。血管内超声用于将冠状动脉节段定义如下:主要为纤维性动脉粥样硬化斑块(高回声)、主要为富含脂质的动脉粥样硬化斑块(低回声)以及无动脉粥样硬化斑块。

结果

在IVUS检查中,识别出20个有纤维斑块的冠状动脉节段、20个有富含脂质斑块的节段和20个无斑块的冠状动脉节段。任何冠状动脉粥样硬化斑块节段的冠状动脉周围脂肪组织平均CT衰减值为 - 34±14亨氏单位(HU),而无斑块节段为 - 56±16 HU(P = 0.005)。IVUS定义的有纤维斑块与富含脂质斑块节段的冠状动脉周围脂肪密度无显著差异( - 35±19 HU对 - 36±16 HU,P = 0.8)。

结论

正常冠状动脉节段与动脉粥样硬化冠状动脉节段相比,冠状动脉周围脂肪组织的平均CT衰减值明显更低。这支持了关于不同类型冠状动脉周围脂肪组织的假说其中代谢活性更高的脂肪组织可能对冠状动脉产生局部影响,从而促进动脉粥样硬化的发生。

相似文献

1
CT Attenuation of Pericoronary Adipose Tissue in Normal Versus Atherosclerotic Coronary Segments as Defined by Intravascular Ultrasound.血管内超声定义的正常与动脉粥样硬化冠状动脉节段中冠状动脉周围脂肪组织的CT衰减值
J Comput Assist Tomogr. 2017 Sep/Oct;41(5):762-767. doi: 10.1097/RCT.0000000000000589.
2
In vivo CT detection of lipid-rich coronary artery atherosclerotic plaques using quantitative histogram analysis: a head to head comparison with IVUS.利用定量直方图分析在体 CT 检测富含脂质的冠状动脉粥样硬化斑块:与 IVUS 的头对头比较。
Atherosclerosis. 2011 Mar;215(1):110-5. doi: 10.1016/j.atherosclerosis.2010.12.006. Epub 2010 Dec 16.
3
Coronary vessel and luminal area measurement using dual-source computed tomography in comparison with intravascular ultrasound: effect of window settings on measurement accuracy.与血管内超声相比,利用双源计算机断层扫描测量冠状动脉血管及管腔面积:窗宽设置对测量准确性的影响
J Comput Assist Tomogr. 2011 Jan-Feb;35(1):113-8. doi: 10.1097/RCT.0b013e3181f7cb30.
4
Assessment of coronary artery remodelling by dual-source CT: a head-to-head comparison with intravascular ultrasound.双源 CT 评估冠状动脉重构:与血管内超声的对头比较。
Heart. 2011 Jun;97(12):991-7. doi: 10.1136/hrt.2011.223024. Epub 2011 Apr 8.
5
Effect of tube potential and luminal contrast attenuation on atherosclerotic plaque attenuation by coronary CT angiography: In vivo comparison with intravascular ultrasound.冠状动脉 CT 血管造影中管电压和管腔对比度衰减对动脉粥样硬化斑块衰减的影响:与血管内超声的体内比较。
J Cardiovasc Comput Tomogr. 2019 Jul-Aug;13(4):219-225. doi: 10.1016/j.jcct.2019.02.004. Epub 2019 Feb 12.
6
Pericoronary adipose tissue ratio is a stronger associated factor of plaque vulnerability than epicardial adipose tissue on coronary computed tomography angiography.在冠状动脉计算机断层扫描血管造影中,冠状动脉周围脂肪组织比率比心外膜脂肪组织更能成为斑块易损性的相关因素。
Heart Vessels. 2017 Jul;32(7):813-822. doi: 10.1007/s00380-017-0943-1. Epub 2017 Feb 22.
7
CT-based analysis of pericoronary adipose tissue density: Relation to cardiovascular risk factors and epicardial adipose tissue volume.基于CT的冠状动脉周围脂肪组织密度分析:与心血管危险因素及心外膜脂肪组织体积的关系
J Cardiovasc Comput Tomogr. 2016 Jan-Feb;10(1):52-60. doi: 10.1016/j.jcct.2015.07.011. Epub 2015 Jul 29.
8
Pericoronary Adipose Tissue Computed Tomography Attenuation and High-Risk Plaque Characteristics in Acute Coronary Syndrome Compared With Stable Coronary Artery Disease.对比稳定型冠心病,急性冠状动脉综合征患者的冠状动脉旁脂肪组织 CT 衰减值与高危斑块特征。
JAMA Cardiol. 2018 Sep 1;3(9):858-863. doi: 10.1001/jamacardio.2018.1997.
9
Association of pericoronary fat volume with atherosclerotic plaque burden in the underlying coronary artery: a segment analysis.冠状动脉周围脂肪体积与基础冠状动脉粥样硬化斑块负担的相关性:节段分析。
Atherosclerosis. 2010 Jul;211(1):195-9. doi: 10.1016/j.atherosclerosis.2010.02.013. Epub 2010 Feb 19.
10
Influence of slice thickness and reconstruction kernel on the computed tomographic attenuation of coronary atherosclerotic plaque.冠状动脉粥样硬化斑块 CT 衰减值受层厚和重建核的影响。
J Cardiovasc Comput Tomogr. 2010 Mar-Apr;4(2):110-5. doi: 10.1016/j.jcct.2010.01.013. Epub 2010 Jan 21.

引用本文的文献

1
Influence of specific components of pericardial fat on coronary high-risk plaque prediction.心包脂肪特定成分对冠状动脉高危斑块预测的影响。
Quant Imaging Med Surg. 2025 Aug 1;15(8):7309-7322. doi: 10.21037/qims-24-1140. Epub 2025 Jul 29.
2
Predictive Value of Peri-Coronary Fat Attenuation Index in Elderly Non-ST-Elevation Myocardial Infarction and Its Correlation with Platelet to Lymphocyte Ratio.冠状动脉周围脂肪衰减指数在老年非ST段抬高型心肌梗死中的预测价值及其与血小板淋巴细胞比值的相关性
BMC Cardiovasc Disord. 2025 Apr 18;25(1):298. doi: 10.1186/s12872-025-04730-8.
3
Diagnostic potential of pericoronary adipose tissue mean attenuation for coronary atherosclerotic heart disease: a comparative analysis with the fat attenuation index.
冠状动脉周围脂肪组织平均衰减对冠状动脉粥样硬化性心脏病的诊断潜力:与脂肪衰减指数的比较分析
Quant Imaging Med Surg. 2025 Apr 1;15(4):3148-3160. doi: 10.21037/qims-24-828. Epub 2025 Mar 28.
4
Effect of statin therapy on coronary inflammation assessed by pericoronary adipose tissue computed tomography attenuation.他汀类药物治疗对通过冠状动脉周围脂肪组织计算机断层扫描衰减评估的冠状动脉炎症的影响。
Eur Heart J Cardiovasc Imaging. 2025 Apr 30;26(5):784-793. doi: 10.1093/ehjci/jeaf062.
5
Predictive Value of Epicardial Adipose Tissue for Hemorrhagic Transformation and Functional Outcomes in Acute Ischemic Stroke Patients Undergoing Intravenous Thrombolysis Therapy.心外膜脂肪组织对接受静脉溶栓治疗的急性缺血性卒中患者出血转化及功能结局的预测价值
J Inflamm Res. 2024 Dec 31;17:11915-11929. doi: 10.2147/JIR.S499351. eCollection 2024.
6
Perivascular Fat: A Novel Risk Factor for Coronary Artery Disease.血管周围脂肪:冠状动脉疾病的一种新危险因素。
Diagnostics (Basel). 2024 Aug 22;14(16):1830. doi: 10.3390/diagnostics14161830.
7
Relationship between pericoronary adipose tissue attenuation value and image reconstruction parameters.冠状动脉周围脂肪组织衰减值与图像重建参数之间的关系。
Heliyon. 2024 Jul 16;10(14):e34763. doi: 10.1016/j.heliyon.2024.e34763. eCollection 2024 Jul 30.
8
Protocol and rationale of the Australian multicentre registry for serial cardiac computed tomography angiography (ARISTOCRAT): a prospective observational study of the natural history of pericoronary adipose tissue attenuation and radiomics.澳大利亚心脏计算机断层扫描血管造影系列研究多中心注册研究(ARISTOCRAT)的方案与原理:一项关于冠状动脉周围脂肪组织衰减和放射组学自然史的前瞻性观察研究。
Cardiovasc Diagn Ther. 2024 Jun 30;14(3):447-458. doi: 10.21037/cdt-23-392. Epub 2024 Jun 27.
9
Epicardial and Pericoronary Adipose Tissue, Coronary Inflammation, and Acute Coronary Syndromes.心外膜和冠状动脉周围脂肪组织、冠状动脉炎症与急性冠状动脉综合征
J Clin Med. 2023 Nov 21;12(23):7212. doi: 10.3390/jcm12237212.
10
Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers.血管周脂肪组织作为治疗靶点和临床生物标志物的来源。
Eur Heart J. 2023 Oct 12;44(38):3827-3844. doi: 10.1093/eurheartj/ehad484.